Larvol Delta - Argo-Biopharmaannounced-that-the-US-Food-and-Drug-Administration-FDA-has-granted-Fast-Track-Designation-FTD-to-its-novel-siRNA-therapy-BW20805-for-the-treatment-of-hereditary-angioedema-HAE

BW-20805 - Argo Biopharma

https://www.prnewswire.com/news-releases/argo-biopharma-receives-fda-fast-track-designation-for-bw-20805-an-investigational-sirna-therapy-for-the-treatment-of-hae-302714159.html

Mar 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next